Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...

Zimmer Biomet’s ZBH strategic product launches amid stabilizing market trends bolster our confidence in this stock. Yet, ...

Discover why Zimmer Biomet Holdings (ZBH) is poised for long-term profitability and growth with its expanding product portfolio and improving cash flow.

Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in ...

John Sperling, MD, of Rochester, Minn.-based Mayo Clinic performed the first cases with Zimmer Biomet's OsseoFit stemless shoulder system.

COVID slump in recent times, MedTech companies have demonstrated strong resilience throughout 2024. The global MedTech ...

Within Hips, the company expects the upcoming launches of Z1 HAMMR and Navigation, like OrthoGrid and ROSA posterior in Europe, to drive market share. Zimmer Biomet also currently looks forward to a ...

Zimmer Biomet Holdings Inc (ZBH) stock saw a modest uptick, ending the day at $104.54 which represents a slight increase of $3.00 or 2.95% from the prior close of $101.54. The stock opened at $102 and ...

Zimmer Biomet Holdings Inc (ZBH) stock saw a decline, ending the day at $101.54 which represents a decrease of $-1.59 or -1.54% from the prior close of $103.13. The stock opened at $102.92 and touched ...

Zimmer Biomet Holdings Inc. closed 20.46% short of its 52-week high of $133.90, which the company reached on March 28th.

In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report). The company’s ...